174 related articles for article (PubMed ID: 25850712)
1. Type 2 diabetes mellitus treatment patterns in U.S. nursing home residents.
Zarowitz B; Allen C; O'Shea T; Dalal MR; Haumschild M; DiGenio A
Postgrad Med; 2015 Jun; 127(5):429-37. PubMed ID: 25850712
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents.
Dybicz SB; Thompson S; Molotsky S; Stuart B
Am J Geriatr Pharmacother; 2011 Aug; 9(4):212-23. PubMed ID: 21659006
[TBL] [Abstract][Full Text] [Related]
4. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
Cooke CE; Lee HY; Tong YP; Haines ST
Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
[TBL] [Abstract][Full Text] [Related]
5. Status of diabetes management in the nursing home setting in 2008: a retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management.
Feldman SM; Rosen R; DeStasio J
J Am Med Dir Assoc; 2009 Jun; 10(5):354-60. PubMed ID: 19497549
[TBL] [Abstract][Full Text] [Related]
6. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach.
Nadeau DA
Postgrad Med; 2013 May; 125(3):112-26. PubMed ID: 23748512
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and persistence of sliding scale insulin use among newly admitted elderly nursing home residents with diabetes mellitus.
Pandya N; Thompson S; Sambamoorthi U
J Am Med Dir Assoc; 2008 Nov; 9(9):663-9. PubMed ID: 18992699
[TBL] [Abstract][Full Text] [Related]
8. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities.
Haas LB
J Am Med Dir Assoc; 2007 Oct; 8(8):502-10. PubMed ID: 17931573
[TBL] [Abstract][Full Text] [Related]
9. Complementing insulin therapy to achieve glycemic control.
Barnett AH
Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
[TBL] [Abstract][Full Text] [Related]
10. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
Blonde L; Baker DE; Davis SN; Ratner RE
J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
[TBL] [Abstract][Full Text] [Related]
11. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
[TBL] [Abstract][Full Text] [Related]
12. Beyond glycemic control: treating the entire type 2 diabetes disorder.
Brunton S
Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
[TBL] [Abstract][Full Text] [Related]
13. Update on diabetes in the elderly and in nursing home residents.
Migdal A; Yarandi SS; Smiley D; Umpierrez GE
J Am Med Dir Assoc; 2011 Nov; 12(9):627-632.e2. PubMed ID: 22018016
[TBL] [Abstract][Full Text] [Related]
14. Differences in diabetes management of nursing home patients based on functional and cognitive status.
McNabney MK; Pandya N; Iwuagwu C; Patel M; Katz P; James V; Calabrese B; Lawhorne L
J Am Med Dir Assoc; 2005; 6(6):375-82. PubMed ID: 16286058
[TBL] [Abstract][Full Text] [Related]
15. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
Nadeau DA
Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.
Deacon CF; Mannucci E; Ahrén B
Diabetes Obes Metab; 2012 Aug; 14(8):762-7. PubMed ID: 22471248
[TBL] [Abstract][Full Text] [Related]
17. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
Pi-Sunyer FX
Postgrad Med; 2008 Jul; 120(2):5-17. PubMed ID: 18654064
[TBL] [Abstract][Full Text] [Related]
18. Incorporating glucagon-like peptide-1 receptor agonists into clinical practice.
Spellman CW
J Am Osteopath Assoc; 2012 Jan; 112(1 Suppl 1):S7-15. PubMed ID: 22267302
[TBL] [Abstract][Full Text] [Related]
19. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
20. Incretin therapies in the management of elderly patients with type 2 diabetes mellitus.
Bourdel-Marchasson I; Schweizer A; Dejager S
Hosp Pract (1995); 2011 Feb; 39(1):7-21. PubMed ID: 21441754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
